Pharmaceutical

Pharmaceutical articles

Parabens in underarm products may lead to breast cancer in women
New research into the potential link between parabens and breast cancer has found traces of the chemicals in breast tissue samples from all of the women in the study. Parabens are commonly used as preservatives in cosmetics, food products and pharmaceuticals.

New cancer drug development institute at UT MD Anderson
Academic and government leaders announced the establishment of a major new research institute at The University of Texas MD Anderson Cancer Center that will blend the best attributes of academic and industrial research to identify and validate new cancer targets, convert such scientific knowledge into new cancer drugs, and advance these novel agents into innovative clinical trials.

Alpharadin improved survival in advanced prostate cancer patients
Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported recently at the 2011 European Multidisciplinary Cancer Congress.

New drug development program for children with HIV AIDS
The Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS. Because HIV transmission in young children has largely been eliminated in high-income countries due to effective prevention of mother-to-child transmission (PMTCT) interventions, little market incentive exists for pharmaceutical companies to develop antiretroviral (ARV) drugs adapted for children.

RISPERDAL and Risperidone Tablets recalled due to odor of TBA
Ortho-McNeil-Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and one lot of risperidone 2mg Tablets, marketed by Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Cannabis may offer relief to patients with chronic pain
The medicinal use of cannabis has been debated by clinicians, researchers, legislators and the public at large for many years as an alternative to standard pharmaceutical treatments for pain, which may not always be effective and may have unwanted side effects.

Cognitive behavior therapy improves ADHD symptoms in adults
Adding cognitive behavioral therapy – an approach that teaches skills for handling life challenges and revising negative thought patterns – to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients.

Shark cartilage drug AE-941 does not improve lung cancer survival
The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May_26 in the Journal of the National Cancer Institute.

Law to prevent doctors from taking pharma gifts
Indian government would frame a law to prevent doctors from receiving gifts and cash from pharmaceutical companies and drug pharmacies, intended by Indian health minister Gulam Nabi Azad.

Vioxx trial data shows early heart risk
US researchers revealed that the heart complications after taking Vioxx, the nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer Merck pulled the drug from the market.

FDA declines Fusilev NDA for colorectal cancer
A Complete Response letter is issued by the U.S. Food and Drug Administration (FDA) regarding the supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.

India to control spurious drugs
The Indian Minister for Health & Family Welfare, Ghulam Nabi Azad has announced whistle blower policy to attract involvement of public to provide information on any kind of unlawful activity in the manufacture of drugs.

Influenza patients may get Shionogi's Peramivir soon
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced positive results from two Phase 3 studies of intravenous (i.v.) peramivir in patients with seasonal influenza.

GSK's cervical cancer vaccine Cervarix got WHO prequalification
The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline's cervical cancer vaccine. GlaxoSmithKline pharmaceutical company applied for WHO prequalification of Cervarix 2 years ago.

Option Inferior Vena Cava Filter gets FDA clearance in US
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, for use in both permanent and retrievable indications.

Zydus Cadila files IND with DCGI to treat diabetes
Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies, has filed IND (Investigational New Drug) application for anti diabetic and anti obesity drug with Drugs Controller General of India (DCGI).

Swine flu vaccine candidate prepared by UK
A strain of virus suitable for vaccine manufacture has now been produced and is being made available to the pharmaceutical industry and other flu laboratories.

Risperdal Consta approved for bipolar disorder
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.

GenWay Biotech distributor of AMDL's DR-70 cancer test in US and Canada
GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL's DR-70 (FDP) cancer test in both the United States and Canada.

Pharmaceutical promotional items influence medical students
Exposure to small promotional items from pharmaceutical companies, such as clipboards and notepads, appears to influence medical students' unconscious attitudes toward the marketed product, according to a report in the May 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Fanapt iloperidone approved for schizophrenia treatment
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that the US Food and Drug Administration (FDA) has granted marketing approval of Fanapt (iloperidone) for the acute treatment of adult patients with schizophrenia.

Swine influenza vaccine soon by Lipoxen, UK
Lipoxen plc (AIM:LPX) ("Lipoxen" or "the Company"), a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and siRNA delivery, and Cambridge Biostability Ltd (CBL), the developer of temperature stable vaccines and biopharmaceuticals, are pleased to announce that they have achieved positive preclinical results for the delivery of a novel and enhanced influenza vaccine based on the combination of Lipoxen's novel vaccine delivery system ‘ImuXen' and CBL's proprietary VitRIS stabilisation platform.

RPSGB warns against counterfeit drugs for swine flu
The Royal Pharmaceutical Society of Great Britain (RPSGB) issued a warning to the public about the risks of buying online medicines for swine influenza, such as Tamiflu or Relenza.

UCL–Pfizer to develop stem cell sight therapies
UCL has entered into a collaboration with the biopharmaceutical group Pfizer, negotiated by UCL Business, to advance development of stem cell-based therapies for age-related macular degeneration (AMD).

Advice for treatment of cough, colds in children under 6
Responding to guidance issued by the Medicines and Healthcare products Regulatory Agency (MHRA), advising that cough and cold treatments should not be used for children under 6 years of age, the Royal Pharmaceutical Society of Great Britain (RPSGB) has issued the following advice to parents.

Clinical trials overseas raises quality control issues
Top-tier U.S.-based pharmaceutical companies are moving their clinical trials overseas at warp speed, raising questions about ethics, quality control, and even the scientific value of their findings for people back in the U.S.

Takeda's Uloric febuxostat approved for hyperuricemia in gout
Teijin Pharma Limited and Takeda Pharmaceutical Company Limited announced that on February 13, 2009, Takeda Pharmaceuticals North America, Inc., received FDA marketing approval for ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout.

Influenza vaccines studies determined by the sponsor
Industry-sponsored studies on influenza vaccines are published in journals with higher rankings (impact factors) and are cited more than studies with other sponsors, but this is not because they are bigger or better, finds a study published on bmj.com today.

US prioritizing health care reform
US people elected new government with a mandate for change and health care is an area that requires reform. Faced with a barrage of pressing issues, the Obama administration has placed healthcare reform high on its agenda.

Weight loss pills may be risky for health
The U.S. Food and Drug Administration is alerting consumers nationwide not to purchase or consume more than 25 different products marketed for weight loss because they contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk.

109 medicines, vaccines in development for HIV AIDS
America's pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

New drug tasimelteon for jet lag
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world's leading medical journals, results of clinical trials of its novel circadian regulator, experimental compound tasimelteon (VEC-162).

14 drugs identified for off label use
Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval - a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it.

Gardasil vaccine to prevent cervical cancer in India
MSD Pharmaceuticals India announced the launch of GARDASIL Vaccine, India's first vaccine to help prevent Cervical Cancer caused by the HPV.

Eli Lilly denied NYT report of schizophrenia drug Zyprexa
Eli Lilly and Company (NYSE: LLY) called the assertions in a New York Times online article 'flat out wrong.' A report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved by federal regulators.

Illinois to strengthen drinking water protections
Following reports that found trace amounts of pharmaceuticals in the US's drinking water, Illinois Governor Rod R. Blagojevich announced that the Illinois Environmental Protection Agency (Illinois EPA) is expanding its current monitoring of water quality to include sampling to determine levels of pharmaceuticals that may be in Illinois waterways.

Duragesic 25 mcg/hr CII pain patches recalled
DURAGESIC 25 mcg/hr (fentanyl transdermal system) CII patches for pain have been recalled because of a cut along one side of the drug reservoir within the patch. Fentanyl patches that are cut or damaged in any way may lead to serious adverse events.

Vytorin does not appear to be unsafe - American Heart Association
Merck/Schering-Plough Pharmaceuticals released results from the ENHANCE trial, which found that the ezetimibe/simvastatin (Zetia/Zocor) combination drug known as Vytorin was no more effective in reducing artery plaque build-up than simvastatin (Zocor) alone. There were no statistically significant differences in the safety of the drugs, which are used to lower cholesterol.

Ortho Evra contraceptive transdermal birth control patch label update
The U.S. Food and Drug Administration (FDA) approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.

Enbrel, etanercept improved psoriasis in children and adolescents
A Phase 3 study showed that children and adolescents with moderate to severe plaque psoriasis who received treatment with Enbrel experienced significant improvements in the signs and symptoms of their disease psoriasis.

40 Pharmaceutical articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.84